Heart attack patients who were treated with the low-cost beta blocker metoprolol on their way to the hospital had 20% less heart tissue damage than those who received a placebo, according to a study in the journal Circulation. Patients with less heart tissue damage are less likely to need an implantable defibrillator and other expensive treatments or require long hospitalization, researchers said.
Beta blocker may help reduce heart attack damage, study finds
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||